Identification of papillomavirus types and other risk factors for cervical intraepithelial neoplasia;Identificação de tipos de papilomavirus e de outros fatores de risco para neoplasia intra-epitelial cervical

Revista Brasileira de Ginecologia e Obstetricia

Volumn 28, Issue 5, 2006, Pages 285-291

  Da Silva, Terezinha Tenório ^a,b   Guimarães, Mariléa De Lima ^a   Barbosa, Maria Isabel De Castro ^a   Pinheiro, Maria De Fátima Garpar ^a   Maia, Angelina Farias ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

^b NONE   (Brazil)

Author keywords

Cervical intra epithelial neoplasia; Polymerase chain reaction; Risk factors; Sexually transmitted diseases; Smoking

Indexed keywords

EID: 33748853892     PISSN: 01007203     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0100-72032006000500004     Document Type: Article

References (24)

1. Franco EL, Duarte-Franco E, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papillomavirus infection. CMAJ. 2001;164(7):1017-25.
2. Bosch FX, Manos MN, Muñoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J Natl Cancer Inst. 1995;87(11):796-802.
3. Ting Y, Manos MM. Detection and typing of genital human papillomavirus. In: Innis A, Gelfand DH, Sninsky JJ, White TJ, editors. PCR protocols: a guide to methods and applications. New York: Academic Press; 1990. p. 356-67.
4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-9.
5. Schelesselman JJ. Case-control studies. Design, conduct, analysis. 3rd ed. New York: Oxford University Press; 1982.
6. Sociedade Brasileira de Patologia do Trato Genital Inferior e Colposcopia (SBPTGIC). Terminologia colposcópica. Bol Inf Dir SBPTGIC. 2003;(5):5-6.
7. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol. 1990;75(1):131-3.
8. Berek JS. Simplification of the new Bethesda 2001 classification system. Am J Obstet Gynecol. 2003;188(3 Suppl):S2-5.
9. National Center for Biotechnology (NCBI). Nucleotide Sequence Update.[cited 2004 Sep 25] available from: http://www.ncbi.nlm.nih.gov
10. Lorenzato F, Ho L, Terry G, Singers A, Santos LC, De Lucena Batista R, et al. The use of human papillomavirus typing in detection of cervical neoplasia in Recife (Brazil). Int J Gynecol Cancer. 2000;10(2):143-50.
11. Frega A, Stentella P, De Ioris A, Piazze JJ, Fambrini M, Marchionni M, et al. Young women, cervical intraepithelial neoplasia and human papillomavirus: risk factors for persistence and recurrence. Cancer Lett. 2003;196(2):127-34.
12. Ho GY, Studentsov Y, Hall CB, Bierman R, Beardsley L, Lempa M, et al. Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 viruslike particles. J Infect Dis. 2002;186(6):737-42.
13. Shapiro S, Rosenberg L, Hoffman M, Kelly JP, Cooper DD, Carrara H, et al. Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa). Cancer Causes Control. 2003;14(5):485-95.
14. Giuliano AR, Sedjo RL, Roe DJ, Harris R, Baldwi S, Papenfuss MR, et al. Clearence of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States). Cancer Causes Control. 2002;13(9):839-46.
15. Yokoyama M, Iwasaka T, Nagata C, Nozawa S, Sekiya S, Hirai Y, et al. Prognostic factors associated with the clinical outcome of cervical intraepithelial neoplasia: a cohort study in Japan. Cancer Lett. 2003;192(2):171-9.
16. Rabelo-Santos SH, Zeferino L, Villa LL, Sobrinho JP, Amaral RG, Magalhães AV. Human papillomavirus prevalence among women with cervical intraepithelial neoplasia III and invasive cervical cancer from Goiania, Brazil. Mem Inst Oswaldo Cruz. 2003;98(2):181-4.
17. Camara GN, Cerqueira DM, Oliveira AP, Silva EO, Carvalho LG, Martins CR. Prevalence of human papillomavirus types in women with pre-neoplastic and neoplastic cervical lesions in the Federal District of Brazil. Mem Inst Oswaldo Cruz. 2003;98(7):879-83.
18. Wright TC Jr, Schiffman M, Solomon D, Cox JT, Garcia F, Goldie S, et al. Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol. 2004;103(2):304-9.
19. Chang DY, Chen RJ, Lee SC, Huang SC. Prevalence of single and multiple infection with human papillomavirus in various grades of cervical neoplasia. J Med Microbiol. 1995;46(1):54-60.
20. Ho GY, Studentsov YY, Bierman R, Burk RD. Natural history of human papillomavirus type 16 virus-like particle antibodies in young women. Cancer Epidemiol Biomarkers Prev. 2004;13(1):110-6.
21. Schiffman M, Herrero R, Desalle R, Hildesheim A, Wacholder S, Rodriguez AC, et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology. 2005;337(1):76-84.
22. Harper DM, Longacre MR, Noll WW, Belloni DR, Cole BF. Factors affecting the detection rate of human papillomavirus. Ann Fam Med. 2003;1(4):221-7.
23. Cuschieri KS, Cubie HA. The role of human papillomavirus testing in cervical screening. J Clin Virol. 2005;32 Suppl 1:S34-42.
24. Derchain SFM, Longatto Filho A, Syrjanen KJ. Neoplasia intra-epitelial cervical: diagnóstico e tratamento. Rev Bras Ginecol Obstet. 2005;27(7):425-33.